Bionano Genomics, Inc.
NASDAQ:BNGO
0.195 (USD) • At close December 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|
| Revenue
| 36.116 | 27.802 | 17.981 | 8.503 | 10.13 | 12.001 | 9.505 | 6.793 |
| Cost of Revenue
| 26.55 | 21.857 | 14.107 | 5.73 | 6.768 | 8.711 | 6.031 | 3.579 |
| Gross Profit
| 9.566 | 5.945 | 3.874 | 2.773 | 3.361 | 3.289 | 3.475 | 3.214 |
| Gross Profit Ratio
| 0.265 | 0.214 | 0.215 | 0.326 | 0.332 | 0.274 | 0.366 | 0.473 |
| Reseach & Development Expenses
| 54.032 | 49.047 | 22.485 | 10.256 | 9.081 | 9.484 | 12.009 | 11.432 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 14.22 | 14.08 | 12.951 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 94.961 | 88.596 | 58.49 | 31.068 | 20.155 | 14.22 | 14.08 | 12.951 |
| Other Expenses
| 75.818 | -0.223 | -0.059 | -2.555 | -3.94 | -0.676 | -0.289 | -0.203 |
| Operating Expenses
| 224.811 | 137.643 | 80.975 | 41.324 | 29.236 | 23.704 | 26.089 | 24.383 |
| Operating Income
| -215.245 | -131.698 | -77.101 | -38.551 | -25.875 | -20.415 | -23.219 | -21.168 |
| Operating Income Ratio
| -5.96 | -4.737 | -4.288 | -4.534 | -2.554 | -1.701 | -2.443 | -3.116 |
| Total Other Income Expenses Net
| -17.186 | 0.986 | -1.051 | -2.526 | -3.919 | 1.934 | -0.128 | 2.333 |
| Income Before Tax
| -232.431 | -130.712 | -78.152 | -41.106 | -29.815 | -18.481 | -23.347 | -18.836 |
| Income Before Tax Ratio
| -6.436 | -4.702 | -4.346 | -4.834 | -2.943 | -1.54 | -2.456 | -2.773 |
| Income Tax Expense
| 0.062 | 1.884 | -5.717 | 0.029 | 0.021 | 0.016 | 0.019 | 0.013 |
| Net Income
| -232.493 | -132.596 | -72.435 | -41.136 | -29.836 | -18.496 | -23.365 | -18.849 |
| Net Income Ratio
| -6.437 | -4.769 | -4.028 | -4.838 | -2.945 | -1.541 | -2.458 | -2.775 |
| EPS
| -6.81 | -4.58 | -2.62 | -3.95 | -19.92 | -26.14 | -86.5 | -36.06 |
| EPS Diluted
| -6.81 | -4.58 | -2.62 | -3.95 | -19.92 | -26.14 | -86.5 | -36.06 |
| EBITDA
| -213.604 | -120.315 | -73.855 | -37.083 | -26.38 | -15.779 | -21.252 | -17.251 |
| EBITDA Ratio
| -5.914 | -4.691 | -4.278 | -4.534 | -2.554 | -1.757 | -2.251 | -2.982 |